---
$id: https://graph.org.ai/products/commodity/51332816
$type: Product
source: UNSPSC
code: "51332816"
title: "Metofenazate"
class: "51332800"
classTitle: "Antipsychotic phenothiazines"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metofenazate

**UNSPSC Code**: 51332816
**Class**: [Antipsychotic phenothiazines](Antipsychotic phenothiazines.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phenothiazine with the molecular formula C31H36ClN3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 27J5OW8OGT, chemically known as 2-(4-(3-(2-chlorophenothiazin-10-yl)propyl)-1-piperazinyl)ethyl 3,4,5-trimethoxybenzoate but generally known as metofenazate, which bears US NIH Compound Identifier 9800. European Medicines Agency schedules Metofenazate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08903MIG. The term METOFENAZATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). METOFENAZATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metofenazate under HS 29343090 and SITC 51578. As of Q4 2014, METOFENAZATE remains the US FDA Preferred Term for this commodity. Metofenazate bears US NLM identifiers UMLS ID C0066466 and NCI Concept Code C66132. SMILES: CLC1CC2N(CCCN3CCN(CC3)CCOC(=O)C3CC(OC)C(OC)C(OC)C3)C3C(SC2CC1)CCCC3.

